High-dose-rate intraluminal brachytherapy for bile duct carcinoma after surgery.
Five patients with recurrent or residual bile duct carcinoma after surgery were treated with high-dose-rate intraluminal brachytherapy (HDRIBT) using a remote afterloader. External radiotherapy was also given in three cases. HDRIBT is considered to be an effective mode of radiotherapy for residual or recurrent bile duct tumors.
Kurisu
K
K
Department of Radiology, Hyogo College of Medicine, Japan.
Hishikawa
Y
Y
Taniguchi
M
M
Kamikonya
N
N
Miura
T
T
Kanno
H
H
Okamoto
E
E
D001650:Bile Duct Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D001918:Brachytherapy; D002763:Cholecystectomy; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control / Q000532:radiotherapy; D010166:Palliative Care; D011182:Postoperative Care; D011882:Radiotherapy, High-Energy